Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients

Published:2019-01 Issue:1 Volume:30 Page:109-114
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Matikas A.,Foukakis T.^ORCID,Moebus V.,Greil R.,Bengtsson N. -O.,Steger G.G.,Untch M.,Johansson H.,Hellström M.,Malmström P.,Gnant M.,Loibl S.,Bergh J.

Funder

Swedish Cancer Society to the Karolinska Institutet

Swedish Breast Cancer Association

BRO

Swedish Breast Cancer Group

SweBCG

Karolinska University Hospital

German Breast Group

GBG

Austrian Breast & Colorectal Cancer Study Group

ABCSG

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/30/1/109/27511326/mdy475.pdf

Reference18 articles.

1. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100, 000 women in 123 randomised trials;Peto;Lancet,2012

2. R Gray , R Bradley, J Braybooke et al Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: an EBCTCG meta-analysis of 21,000 women in 16 randomised trials. In San Antonio Breast Cancer Symposium, San Antonio, TX, USA, 2017. Abstract GS1-01.

3. Obesity and breast cancer prognosis: evidence, challenges, and opportunities;Jiralerspong;J Clin Oncol,2016

4. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline;Griggs;J Clin Oncol,2012

5. Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study;Furlanetto;Ann Oncol,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial;Journal of Clinical Oncology;2024-09-10

2. The Role of Obesity and Inflammation in Breast Cancer Recurrence;Current Breast Cancer Reports;2024-05-18

3. Dual-microRNA triggered and DNA-programmed nanomachine for subtype-based detection and tailored treatment of breast cancer cells;Biomedical Analysis;2024-03

4. Impact of BMI in Patients With Early Hormone Receptor–Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial;Journal of Clinical Oncology;2023-11-20

5. Adjuvant Dose Dense Chemotherapy in Patients With Obesity: Short-Term Toxicities and Breast Cancer Outcome;Clinical Breast Cancer;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3